Indomethacin, a non-steroid anti-idammatory drug, was given to 28 patients with acute rheumatic fever or chorea, and its effects compared to 23 similar patients given aspirin. No significant differences were observed either in effects on acute phase manifestations or the incidence of valvular heart disease one year later. Because of the incidence of side efiects in other studies, indomethacin would appear to offer no advantage over aspirin in the therapy of rheumatic fever. NDOMETHACIN,* AN ANTI-INFLAMMATORY agent unrelated to I adrenocortical steroids, has been shown to provide -symptomatic relief in rheumatoid arthritis and other joint diseases.1-5 The present study was designed to compare the effects of indomethacin and aspirin on acute rheumatic fever and its valvular sequelae. MATERIALS AND METHODSTlic study was conducted in the winter of 1962 at the Jose Joaquin Aquirre. Roberto del Rio arid hlanuel Arriarlin hospitals of the University of Chile and the National Health Service, Santiago, Chile. Children and adults hospitalized with suspected acute rheumatic fever were observed and a complete history and physical examination performed. Initial laboratory studies included a sedimentation rate, hematocrit, standard PA chest film for heart size and an electrocardiogram. h serum specimen was taken for antistreptolysin 0 and C-reactive protein determinations. If a patient failed to meet the criteria for admission to the study, the examinations were repeated until a diagnosis was established. All patients diagnosed as having acute rheumatic fever according to the modified criteria of Jones6 were accepted for study. During the observed attack at least one major and two minor criteria or two major criteria must have been present. In addition, on the day therapy was
De 463 Cardiopatfas Congenitas actualmente en control en el Servicio de Cardiologia del Hospital Clinico de Ninos "Roberto del Rio", se ban seleccionado y entregado al Servicio de Cirugia del mismo hospital para su intervencion, entre los anos 1949 y 1953, 59 enfermos, que se desglosan de la siguiente manera:Es alrededor de la sintomatologia pre y post-operatoria de estos casos que haremos algunas consideraciones clinicas. PERSISTENCIA DEL CONDUCTO ARTERIO-VENOSO(34 casos)De los 34 casos con esta cardiopatia, 5 fueron hombres y 29 mujeres, es decir que hubo una relacion de 1:6. De la edad en que estos enfermos se operaron, primo con mucho la de 7 y 8 anos.En la mitad de los casos no hubo sintomas subjetivos de cardiopatia y el hallazgo de ella en muchas ocasiones fue casual. Otros enfermos presentaron los sintomas y signos propios de esta malformacion cardiaca, que se pueden observar en el cuadro N° 1:La disnea de esfuerzo se observo en 15 enfermos, sintoma que no fue de gran intensidad, a excepcion de 4 casos que presentaron insuficiencia cardiaca congestiva, la que seguramente estuvo en relacion con un gran shunt arterio-venoso, dado en tamano del ductus encontrado en la intervencion.En 16 enfermos hubo epistaxis que persistio en 2 de ellos en su evolucion posterior, aunque con menor intensidad.Hubo procesos broncopulmonares a repeticion en 10 enfermos, que se han repetido en 1 caso (nino menor de 2 anos).Esta cardiopatia entrabo el desarrollo normal, tanto en talla como en peso, en 19 ninos. La hipotrofia tenia como causa la cardiopatia, ya que 12 de ellos, despues de su intervencion, alcanzaron el desarrollo normal en relacion a su edad. Siete persisten con peso y talla deficientes, pero buen nurnero de ellos llevan un control por menos de 1 ano. (Grafico 1).En la totalidad de estos ninos hubo presion diferencial aumentada a expensas de la presion minima. En la mayoria de los casos esta oscilo entre 30 y 40 mm. de Hg. Despues de la intervencion la presion minima se normalize. (Grafico N 9 2). CUADRO X* 1 SINTOMAS Y SIGNOS OBSERVADOS EN 34 CASOS DE PERSISTENCIA DEL CONDUCTO ARTERIO-VENOSO
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.